Hearn Jay Cho (Hearn J Cho)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 18

Top Topics

Newly Diagnosed

Multiple Myeloma

Acute Lymphoblastic Leukemia

Top Venues

Journal for immunotherapy of cancer

Blood cancer discovery

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

David G Coffey, Keren Osman, Adolfo Aleman, Selma Bekri, Simone Kats, Amishi Dhadwal, Donna Catamero, Seunghee Kim-Schulze, Sacha Gnjatic, Ajai Chari, Samir Parekh, Sundar Jagannath, Hearn Jay Cho
Phase 1 study combining elotuzumab with autologous stem cell transplant and lenalidomide for multiple myeloma. Journal for immunotherapy of cancer 12 (4) (2024)
Santiago Thibaud, Ryan L Subaran, Scott Newman, Alessandro Lagana, David T Melnekoff, Saoirse Bodnar, Meghana Ram, Zachry Soens, William Genthe, Tehilla E Brander, Tarek H Mouhieddine, Oliver Van Oekelen, Jane Houldsworth, Hearn Jay Cho, Shambavi Richard, Joshua Richter, Cesar Rodriguez, Adriana Rossi, Larysa J Sanchez, Ajai Chari, Erin Laverne Moshier, Sundar Jagannath, Samir S Parekh, Kenan Onel
Multiple Myeloma Risk and Outcomes are Associated with Pathogenic Germline Variants in DNA Repair Genes. Blood cancer discovery (2024)
David G Coffey, Keren Osman, Adolfo Aleman, Selma Bekri, Simone Kats, Amishi Dhadwal, Donna Catamero, Seunghee Kim-Schulze, Sacha Gnjatic, Ajai Chari, Samir Parekh, Sundar Jagannath, Hearn Jay Cho
Phase 1 study combining elotuzumab with autologous stem cell transplant and lenalidomide for multiple myeloma. Journal for immunotherapy of cancer 12 (4) (2024)
David G Coffey, Keren Osman, Adolfo Aleman, Selma Bekri, Simone Kats, Amishi Dhadwal, Donna Catamero, Seunghee Kim-Schulze, Sacha Gnjatic, Ajai Chari, Samir Parekh, Sundar Jagannath, Hearn Jay Cho
Phase 1 study combining elotuzumab with autologous stem cell transplant and lenalidomide for multiple myeloma. Journal for immunotherapy of cancer 12 (4) (2024)
David G Coffey, Keren Osman, Adolfo Aleman, Selma Bekri, Simone Kats, Amishi Dhadwal, Donna Catamero, Seunghee Kim-Schulze, Sacha Gnjatic, Ajai Chari, Samir Parekh, Sundar Jagannath, Hearn Jay Cho
Phase 1 study combining elotuzumab with autologous stem cell transplant and lenalidomide for multiple myeloma. Journal for immunotherapy of cancer 12 (4) (2024)
David G Coffey, Keren Osman, Adolfo Aleman, Selma Bekri, Simone Kats, Amishi Dhadwal, Donna Catamero, Seunghee Kim-Schulze, Sacha Gnjatic, Ajai Chari, Samir Parekh, Sundar Jagannath, Hearn Jay Cho
Phase 1 study combining elotuzumab with autologous stem cell transplant and lenalidomide for multiple myeloma. Journal for immunotherapy of cancer 12 (4) (2024)
Guido Lancman, Kian Parsa, Krzysztof Kotlarz, Lisa Avery, Alaina Lurie, Alex Lieberman-Cribbin, Hearn Jay Cho, Samir S Parekh, Shambavi Richard, Joshua Richter, Cesar Rodriguez, Adriana Rossi, Larysa J Sanchez, Santiago Thibaud, Sundar Jagannath, Ajai Chari
IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies. Blood cancer discovery (2023)
Urvi A Shah, Erin Laverne Moshier, Andriy Derkach, Yuanhui Huang, Sham Mailankody, Carlyn Rose Tan, Kylee H Maclachlan, Malin L Hultcrantz, Neha Korde, Hani Hassoun, Santiago Thibaud, Larysa Sanchez, Cesar Rodriguez, Shambavi Richard, Joshua Richter, Adriana Rossi, Hearn Jay Cho, Alexander M Lesokhin, Ajai Chari, Saad Z Usmani, Sundar Jagannath, Samir Parekh, Emily Jane Gallagher
Prevalence and impact of diabetes on survival of patients with multiple myeloma in different racial groups. Blood advances (2023)
David G Coffey, Francesco Maura, Edgar G Kozlova, J Javier Diaz-Mejia, Ping Luo, Yong Zhang, Yuexin Xu, Edus H Warren, Travis Dawson, Brian Lee, Hui Xie, Eric L Smith, Amanda Ciardiello, Hearn Jay Cho, Adeeb Rahman, Seunghee Kim-Schulze, Benjamin T Diamond, Alexander Lesokhin, Dickran Kazandjian, Trevor J Pugh, Damian J Green, Sacha Gnjatic, Carl Ola Landgren
Immunophenotypic correlates of sustained MRD negativity in patients with multiple myeloma. Nature communications 14 (1) (2023)
Faith E Davies, Charlotte Pawlyn, Saad Z Usmani, Jesús San F Miguel, Hermann Einsele, Eileen Mary Boyle, Jill Corre, Daniel Auclair, Hearn Jay Cho, Sagar Lonial, Pieter Sonneveld, A Keith Stewart, Peter Leif Bergsagel, Martin F Kaiser, Katja Weisel, Jonathan J Keats, Joseph R Mikhael, Kathryn E Morgan, Irene M Ghobrial, Robert Z Orlowski, Carl Ola Landgren, Francesca Gay, Joseph Caers, Wee-Joo Chng, Ajai Chari, Brian A Walker, Shaji K Kumar, Luciano José Megale Costa, Kenneth C Anderson, Gareth J Morgan
Perspectives on the Risk-Stratified Treatment of Multiple Myeloma. Blood cancer discovery 3 (4) (2022)
Paula Restrepo, Sherry Bhalla, Yogita Ghodke-Puranik, Adolfo Aleman, Violetta V Leshchenko, David T Melnekoff, Sarita Agte, Joy J Jiang, Deepu Madduri, Joshua Richter, Shambavi Richard, Ajai Chari, Hearn Jay Cho, Sundar Jagannath, Christopher J Walker, Yosef Landesman, Alessandro Laganà, Samir S Parekh
A Three-Gene Signature Predicts Response to Selinexor in Multiple Myeloma. JCO precision oncology 6 (2022)
Selma Bekri, Reunet Rodney-Sandy, Diana Gruenstein, Anna Mei, Bjarne Bogen, John Castle, Daniel Levey, Hearn Jay Cho
Neoantigen vaccine-induced CD4 T cells confer protective immunity in a mouse model of multiple myeloma through activation of CD8 T cells against non-vaccine, tumor-associated antigens. Journal for immunotherapy of cancer 10 (2) (2022)
Tarek H Mouhieddine, Oliver Van Oekelen, David T Melnekoff, Jeanne Li, Yogita Ghodke-Puranik, Guido Lancman, Santiago Thibaud, Darren Pan, Sridevi Rajeeve, Sarita Agte, Adolfo Aleman, Larysa Sanchez, Shambavi Richard, Adriana Rossi, Joshua Richter, Hearn Jay Cho, Cesar Rodriguez, Alessandro Lagana, Erin L Moshier, Ajai Chari, Sundar Jagannath, Samir Parekh
Sequencing T-cell redirection therapies leads to deep and durable responses in relapsed/refractory myeloma patients. Blood advances (2022)
Tarek H Mouhieddine, Erin Moshier, Santiago Thibaud, Benjamin Puliafito, Mohammad Rattu, Rita Jakubowski, Larysa Sanchez, Adriana Rossi, Cesar Rodriguez, Shambavi Richard, Hearn Jay Cho, Samir Parekh, Ajai Chari, Amir Steinberg, Joshua Richter
Bridging advanced myeloma patients to subsequent treatments and clinical trials with classical chemotherapy and stem cell support. Bone marrow transplantation (2022)
Oliver Van Oekelen, Karthik Nath, Tarek H Mouhieddine, Tasmin Farzana, Adolfo Aleman, David T Melnekoff, Yogita Ghodke-Puranik, Gunjan L Shah, Alexander M Lesokhin, Sergio A Giralt, Santiago Thibaud, Adriana Rossi, Cesar Rodriguez, Larysa Sanchez, Joshua Richter, Shambavi Richard, Hearn Jay Cho, Ajai Chari, Saad Z Usmani, Sundar Jagannath, Urvi A Shah, Sham Mailankody, Samir Parekh
Interventions and outcomes of multiple myeloma patients receiving salvage treatment after BCMA-directed CAR T therapy. Blood (2022)
Guido Lancman, Dahniel L Sastow, Hearn Jay Cho, Sundar Jagannath, Deepu Madduri, Samir S Parekh, Shambavi Richard, Joshua Richter, Larysa Sanchez, Ajai Chari
Bispecific Antibodies in Multiple Myeloma: Present and Future. Blood cancer discovery 2 (5) (2021)
Sherry Bhalla, David T Melnekoff, Adolfo Aleman, Violetta V Leshchenko, Paula Restrepo, Jonathan J Keats, Kenan Onel, Jeffrey R Sawyer, Deepu Madduri, Joshua Richter, Shambavi Richard, Ajai Chari, Hearn Jay Cho, Joel T Dudley, Sundar Jagannath, Alessandro Lagana, Samir S Parekh
Patient similarity network of newly diagnosed multiple myeloma identifies patient subgroups with distinct genetic features and clinical implications. Science advances 7 (47) (2021)
Deepak Perumal, Naoko Imai, Alessandro Laganà, John Finnigan, David Melnekoff, Violetta V Leshchenko, Alexander Solovyov, Deepu Madduri, Ajai Chari, Hearn Jay Cho, Joel T Dudley, Joshua D Brody, Sundar Jagannath, Benjamin Greenbaum, Sacha Gnjatic, Nina Bhardwaj, Samir Parekh
Mutation-derived Neoantigen-specific T-cell Responses in Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (2) (2019)